These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 26562694

  • 41. Substantially reduced incidence of genital warts in women and men six years after HPV vaccine availability in Sweden.
    Herweijer E, Ploner A, Sparén P.
    Vaccine; 2018 Apr 05; 36(15):1917-1920. PubMed ID: 29523448
    [Abstract] [Full Text] [Related]

  • 42. Decline in in-patient treatments of genital warts among young Australians following the national HPV vaccination program.
    Ali H, Guy RJ, Wand H, Read TR, Regan DG, Grulich AE, Fairley CK, Donovan B.
    BMC Infect Dis; 2013 Mar 18; 13():140. PubMed ID: 23506489
    [Abstract] [Full Text] [Related]

  • 43. [Genital warts and HPV vaccination].
    Pilka R, Dvorák V, Fait T.
    Ceska Gynekol; 2011 Dec 18; 76(6):468-70. PubMed ID: 22312844
    [Abstract] [Full Text] [Related]

  • 44. Estimates of the timing of reductions in genital warts and high grade cervical intraepithelial neoplasia after onset of human papillomavirus (HPV) vaccination in the United States.
    Chesson HW, Ekwueme DU, Saraiya M, Dunne EF, Markowitz LE.
    Vaccine; 2013 Aug 20; 31(37):3899-905. PubMed ID: 23820080
    [Abstract] [Full Text] [Related]

  • 45. Random Network Models to Predict the Long-Term Impact of HPV Vaccination on Genital Warts.
    Díez-Domingo J, Sánchez-Alonso V, Villanueva RJ, Acedo L, Moraño JA, Villanueva-Oller J.
    Viruses; 2017 Oct 16; 9(10):. PubMed ID: 29035332
    [Abstract] [Full Text] [Related]

  • 46. Human Papillomavirus and Genital Warts: A Review of the Evidence for the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines.
    Park IU, Introcaso C, Dunne EF.
    Clin Infect Dis; 2015 Dec 15; 61 Suppl 8():S849-55. PubMed ID: 26602622
    [Abstract] [Full Text] [Related]

  • 47. Epidemiology, clinical manifestations, and recent advances in vaccination against human papillomavirus.
    Broomall EM, Reynolds SM, Jacobson RM.
    Postgrad Med; 2010 Mar 15; 122(2):121-9. PubMed ID: 20203463
    [Abstract] [Full Text] [Related]

  • 48. Genital warts and chlamydia in Australian women: comparison of national population-based surveys in 2001 and 2011.
    Liu B, Donovan B, Brotherton JM, Saville M, Kaldor JM.
    Sex Transm Infect; 2014 Nov 15; 90(7):532-7. PubMed ID: 24570485
    [Abstract] [Full Text] [Related]

  • 49. Health service utilisation for anogenital warts in Ontario, Canada prior to the human papillomavirus (HPV) vaccine programme introduction: a retrospective longitudinal population-based study.
    Guerra FM, Rosella LC, Dunn S, Wilson SE, Chen C, Deeks SL.
    BMJ Open; 2016 Mar 10; 6(3):e009914. PubMed ID: 26966057
    [Abstract] [Full Text] [Related]

  • 50. Nonavalent human papillomavirus vaccination as alternative treatment for genital warts.
    Bossart S, Gabutti MP, Seyed Jafari SM, Hunger RE.
    Dermatol Ther; 2020 Jul 10; 33(4):e13771. PubMed ID: 32500585
    [Abstract] [Full Text] [Related]

  • 51. Declines in anogenital warts diagnoses since the change in 2012 to use the quadrivalent HPV vaccine in England: data to end 2017.
    Checchi M, Mesher D, Mohammed H, Soldan K.
    Sex Transm Infect; 2019 Aug 10; 95(5):368-373. PubMed ID: 30723186
    [Abstract] [Full Text] [Related]

  • 52. Human Papillomavirus Infection and Vaccination.
    Valentino K, Poronsky CB.
    J Pediatr Nurs; 2016 Aug 10; 31(2):e155-66. PubMed ID: 26586310
    [Abstract] [Full Text] [Related]

  • 53. HPV vaccine promotion: does referring to both cervical cancer and genital warts affect intended and actual vaccination behavior?
    Juraskova I, Bari RA, O'Brien MT, McCaffery KJ.
    Womens Health Issues; 2011 Aug 10; 21(1):71-9. PubMed ID: 21185992
    [Abstract] [Full Text] [Related]

  • 54. Decreased management of genital warts in young women in Australian general practice post introduction of national HPV vaccination program: results from a nationally representative cross-sectional general practice study.
    Harrison C, Britt H, Garland S, Conway L, Stein A, Pirotta M, Fairley C.
    PLoS One; 2014 Aug 10; 9(9):e105967. PubMed ID: 25180698
    [Abstract] [Full Text] [Related]

  • 55. Significant decrease in the incidence of genital warts in young Danish women after implementation of a national human papillomavirus vaccination program.
    Baandrup L, Blomberg M, Dehlendorff C, Sand C, Andersen KK, Kjaer SK.
    Sex Transm Dis; 2013 Feb 10; 40(2):130-5. PubMed ID: 23324976
    [Abstract] [Full Text] [Related]

  • 56. High prevalence of genital HPV infection among long-term monogamous partners of women with cervical dysplasia or genital warts-Another reason for HPV vaccination of boys.
    Rob F, Tachezy R, Pichlík T, Rob L, Kružicová Z, Hamšíková E, Šmahelová J, Hercogová J.
    Dermatol Ther; 2017 Jan 10; 30(1):. PubMed ID: 27723194
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Real world effectiveness of population-based roll out of human papillomavirus vaccination against rates of genital warts.
    Smith JS, Weiderpass E.
    J Natl Cancer Inst; 2013 Apr 03; 105(7):449-51. PubMed ID: 23486549
    [No Abstract] [Full Text] [Related]

  • 59. Developing an HPV vaccine to prevent cervical cancer and genital warts.
    Bryan JT.
    Vaccine; 2007 Apr 20; 25(16):3001-6. PubMed ID: 17289220
    [Abstract] [Full Text] [Related]

  • 60. The cost-effectiveness of male HPV vaccination in the United States.
    Chesson HW, Ekwueme DU, Saraiya M, Dunne EF, Markowitz LE.
    Vaccine; 2011 Oct 26; 29(46):8443-50. PubMed ID: 21816193
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.